Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry

Mathias Castonguay, Nawar Dakhallah, Marie-Laure Colaiacovo, Camille Jimenez-Cortes, Justin Desroches, Anne-Marie Claveau, Amer Yassine Hafsaoui, Amalia Souza, Pauline Tibout, Anne-Marie Vincent, Veronique Naessens, Josee Brossard, Sharon Abish, Raoul Santiago, Denis Soulieres, Vincent Laroche, Yves D. Pastore, Thai Hoa Tran, Stéphanie Forté

Blood (2021) 138 (Supplement 1): 4064.

https://doi.org/10.1182/blood-2021-151361

Published: 2021

Journal Articles

The Prevalence of Non-Neutralizing Anti-FVIII Antibodies in the Canadian Hemophilia Population.

David Lillicrap, Angie Tuttle, Eric Crawford, Anne-Marie Vincent, Georges E. Rivard, The Association of Hemophilia Clinic Directors of Canada

Blood (2009) 114 (22): 1291.

https://doi.org/10.1182/blood.V114.22.1291.1291

Published: 2009

Journal Articles

The Prevalence of Anti-Factor VIII Antibodies in the Hemophilia A Population of the Quebec Province of Canada: Results of Testing with the Bethesda/Nijmegen Assay and with Three ELISA Assays.

Anne-Marie Vincent, David Lillicrap, Angie Tuttle, Laurence Dedeken, Christine Demers, Mariette Lépine, Jean St-Louis, Margaret Warner, Georges E. Rivard

Blood (2009) 114 (22): 1308.

https://doi.org/10.1182/blood.V114.22.1308.1308

Published: 2009

Journal Articles

Assay of Factor VIII Antibodies by ELISA Using Plasma Specimens Dried On Filter Paper and Stored at Room Temperature.

Anne-Marie Vincent, David Lillicrap, Angie Tuttle, Angélique Hofer, Anik Cormier, Jean St-Louis, Georges E. Rivard

Blood (2009) 114 (22): 3479.

https://doi.org/10.1182/blood.V114.22.3479.3479

Published: 2009

Journal Articles

Use of Factor VIII/Von Willebrand Factor Complex for Inducing Immune Tolerance in Hemophilia a Patients Who Have Failed with Recombinant Fviii: Recent Canadian Experience

Anne-Marie Vincent, M.D., FRCPC, Anthony Chan, MBBS, Sara J. Israels, MD, Man-Chiu Poon, MD, John K. Wu, MBBS, FRCPC, Georges E. Rivard, MD

Blood (2008) 112 (11): 4520.

https://doi.org/10.1182/blood.V112.11.4520.4520

Published: 2008

NARROW

COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry

The Prevalence of Non-Neutralizing Anti-FVIII Antibodies in the Canadian Hemophilia Population.

The Prevalence of Anti-Factor VIII Antibodies in the Hemophilia A Population of the Quebec Province of Canada: Results of Testing with the Bethesda/Nijmegen Assay and with Three ELISA Assays.

Assay of Factor VIII Antibodies by ELISA Using Plasma Specimens Dried On Filter Paper and Stored at Room Temperature.

Use of Factor VIII/Von Willebrand Factor Complex for Inducing Immune Tolerance in Hemophilia a Patients Who Have Failed with Recombinant Fviii: Recent Canadian Experience

Email alerts

ASH Publications

American Society of Hematology

COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry

The Prevalence of Non-Neutralizing Anti-FVIII Antibodies in the Canadian Hemophilia Population.

The Prevalence of Anti-Factor VIII Antibodies in the Hemophilia A Population of the Quebec Province of Canada: Results of Testing with the Bethesda/Nijmegen Assay and with Three ELISA Assays.

Assay of Factor VIII Antibodies by ELISA Using Plasma Specimens Dried On Filter Paper and Stored at Room Temperature.

Use of Factor VIII/Von Willebrand Factor Complex for Inducing Immune Tolerance in Hemophilia a Patients Who Have Failed with Recombinant Fviii: Recent Canadian Experience

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only